MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks

Objective: The safety and impact of the advanced hybrid closed-loop (AHCL) system on glycemic outcome in 2- to 6-year-old children with type 1 diabetes and the diabetes distress of caregivers were evaluated. Research Design and Methods: This was an open-label prospective study ( n = 35) with histor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes technology & therapeutics 2023-02, Vol.25 (2), p.1-107
Hauptverfasser:	Pulkkinen, Mari-Anne, Varimo, Tero J, Hakonen, Elina T, Harsunen, Minna H, Hyvönen, Mervi E, Janér, Joakim N, Kiiveri, Sanne M, Laakkonen, Hanne M, Laakso, Saila M, Wehkalampi, Karoliina, Hero, Matti T, Miettinen, Päivi J, Tuomaala, Anna-Kaisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose Blood Glucose Self-Monitoring Child Clinical outcomes Closed loop systems Diabetes Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Diabetic ketoacidosis Glucose monitoring Glycated Hemoglobin Humans Hypoglycemic Agents - therapeutic use Infusion pumps Insulin Insulin - adverse effects Insulin Infusion Systems Medical technology Original Articles Patient safety Pediatrics Prospective Studies Sensors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective: The safety and impact of the advanced hybrid closed-loop (AHCL) system on glycemic outcome in 2- to 6-year-old children with type 1 diabetes and the diabetes distress of caregivers were evaluated. Research Design and Methods: This was an open-label prospective study ( n = 35) with historical controls matched by treatment unit, diabetes duration, age, gender, and baseline treatment modality. The inclusion criteria were (1) type 1 diabetes diagnosis >6 months, (2) total daily dose of insulin ≥8 U/day, (3) HbA1c
ISSN:	1520-9156 1557-8593
DOI:	10.1089/dia.2022.0313